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Abstract

Supported by The NIH grant R03-DE019177.

AIM: To provoke persistent/chronic multiorgan inflam
matory response and to contribute to stones formation
followed by fibrosis in hepatobiliary and pancreatic tissues.

Institutional animal care and use committee statement: All
animal procedures were approved by the University of Kentucky
Institutional animal care and use committee.

METHODS: tumor necrosis factor receptors 1 and 2
(TNFR1/R2) deficient mice reared in-house were given
dibutyltin dichloride (DBTC) twice within 10 d by oral
gavage delivery. Sham control animals received vehicle
treatment and naïve animals remained untreated
throughout the study. Animals were monitored daily for
symptoms of pain and discomfort. The abdominal and
hindpaw hypersensitivity were assessed with von Frey
microfilaments. Exploratory behaviors were recorded at
the baseline, after initiation of treatment, and before
study termination. Histopathological changes were
examined postmortem in tissues. Collagen accumulation
and fibrosis were confirmed with Sirius Red staining.
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RESULTS: Animals lost weight after oral administration
of DBTC and developed persistent inflammatory
abdominal and hindpaw hypersensitivity compared to
sham-treated controls (p < 0.0001). These pain related
secondary mechanical hypersensitivity responses
increased more than 2-fold in DBTC-treated animals.
The drastically diminished rearing and grooming rates
persisted after DBTC administration throughout the
study. Gross as well as micropathology at one month
confirmed that animals treated with DBTC developed
chronic hepatobiliary injuries evidenced with activation
of stellate cells, multifocal necrosis, fatty degeneration
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of hepatocytes, periportal infiltration of inflammatory
cells, and prominent biliary ductal dilation. The
severity of hepatitis was scored 3.7 ± 0.2 (severe) in
DBTC-treated animals vs score 0 (normal) in shamtreated animals. Fibrotic thickening was extensive
around portal ducts, in hepatic parenchyma as well
as in lobular pancreatic structures and confirmed with
Sirius Red histopathology. In addition, pancreatic
microarchitecture was presented with distortion of
islets, and parenchyma, infiltration of inflammatory
cells, degeneration, vacuolization, and necrosis of
acinar cells and distention of pancreatic ducts. Extent
of pancreatic damage and pancreatitis were scored
3.6 ± 0.4 (severe) for DBTC-treated in contrast to
score 0 (normal) in sham-treated animals. The gall
bladder became expanded with ductal distention,
and occasional bile stones were detected along with
microscopic hepatic lesions. DBTC-treated animals
developed splenic hypertrophy with increased weight
and length (p < 0.01) along with thymic atrophy
(p < 0.001). Finally, colitic lesions and colitis were
prominent in DBTC-treated animals and scored 3.4 ± 0.3
(moderately severe) vs 0 (normal) for the sham-treated
animals.

INTRODUCTION
Fibrogenesis is a required process in wound healing,
but persistent inflammatory and fibrotic reaction can
lead to devastating symptoms and eventually organ
[1,2]
failure . Multiorgan fibrosis is typically the end product
of various unresolved or repetitive tissue injuries from
chronic inflammation, infection, radiation exposure, and
abnormal repair outcome. Loss of function contributes
to progression of morbidity and mortality. Multiorgan
[3]
fibrosis is a common complication in cystic fibrosis ,
[4]
[5]
systemic sclerosis and primary sclerosing cholangitis .
Chronic pancreatitis, initiated by idiopathic or recurrent
inflammation, is manifested with irreversible destruction
of exocrine parenchyma and pancreatic fibrosis. It is a
potentially fatal progressive disease leading to diabetes
mellitus and pancreatic cancer. Pancreatitis is associated
with spontaneous visceral pain as a chief symptom in
patients. Neural innervation of the pancreas is pivotal
in the instigation and continuation of inflammation and
pain response. Cellular destruction leads to activation
of pancreatic sensory neurons causing release of
neurotransmitters in the spinal cord and neurogenic
signaling then back to the pancreas provoking plasma
[6]
extravasation and neutrophil infiltration .
Multifactoral gallstones are one of the most pre
valent gastrointestinal complications with serious
outcomes such as gallstone pancreatitis and cancer.
Gallstone disease is a chronic recurrent hepatobiliary
complication which is characterized by formation of
gallstones in the hepatic and bile duct, or gallbladder.
It is manifested by impaired metabolism of cholesterol,
[7]
bilirubin and bile acids .
Tumor necrosis factor α (TNFα) a proinflammatory
cytokine, up-regulates various cytokines/chemokines
to initiate acute and chronic stages of inflammation.
The biological action of TNFα is chiefly through two
gene family receptors, TNFR1 and TNFR2. TNFα is
released mainly by activated macrophages, in addition
to astroglia, microglia, CD4+ lymphocytes, Natural
[8-10]
killer cells (NK), and neurons
. The complete-length
membrane-crossing TNFα (mTNFα) is sliced by the
inducible TNF converting enzyme (TACE) to release
[11]
soluble TNFα (sTNFα) and diffusible peptide . TNFα
release is associated with inflammatory response and
pain related sensation in patients with pancreatitis,
hepatitis and inflammatory bowel disease (IBD), as well
[12]
as neuropathy . TNFα contributes to development of
[13]
neuropathic pain . Soluble TNFR1 and R2 neutralize
circulating TNFα to alleviate pain related responses
to mechanical allodynia, thermal hyperalgesia or
[14-16]
peripheral nerve injuries
. TNFα plays an important
function in the pathogenesis of acute pancreatitis.
Recent investigations have demonstrated that TNFα
inhibition drastically ameliorates the duration of
[17]
experimental acute pancreatitis . TNFα receptor 1
(TNFR1) gene deletion and etanercept application
likewise ameliorated the duration of acute pancreatitis

CONCLUSION: This is the first report of chronic inflam
matory multiorgan hepatobiliary pancreatitis, along with
fibrosis and calculi formation induced reliably utilizing
oral DBTC administration in TNFR1/R2 deficient mice.
Key words: inflammatory pain; multiorgan; hepatitis;
pancreatitis; calculi formation; gall bladder; hepatobiliary
inflammation
© The Author(s) 2016. Published by Baishideng Publishing
Group Inc. All rights reserved.

Core tip: Currently there is no reliable model for chronic
multiorgan inflammatory and fibrosis. tumor necrosis
factor (TNF)α initiates inflammation through TNFR1/
R2. TNFR1/R2 deficient mice administered orally with
dibutyltin dichloride (DBTC) developed significant
persistent inflammatory and pain related secondary
mechanical hypersensitivity. DBTC-animals showed
severe chronic hepatobiliary injuries and prominent
biliary ductal dilation. Extensive fibrotic thickening
was evidenced around portal ducts, in hepatic and
pancreatic structures. DBTC-animals had severe
pancreatic damage and pancreatitis, hepatic lesions
with expansion of gall bladder, bile stones and severe
colitis. This is the first report of chronic inflammatory
multiorgan hepatobiliary pancreatitis, fibrosis and
calculi formation in TNFR1/R2 deficient mice.
Oz HS. Multiorgan chronic inflammatory hepatobiliary pancreatic
murine model deficient in tumor necrosis factor receptors 1 and 2.
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in animal models, suggesting potential of etanercept
and anti-TNFα monoclonal antibodies as therapy
[17]
in clinical pancreatitis . Although, current clinical
treatments with these biological agents may diminish
inflammation and pain by reducing TNFα and other
cytokines, the inflammatory response and pain is
likely to re-emerge in most patients with autoimmune
[10]
disease including arthritis and IBD . In addition, antiTNFα monoclonal antibodies therapy has potential side
effects such as provoking infections with JC virus, fungi
and tuberculosis. Currently there is no cure or reliable
mouse model for chronic pancreatitis.
Previously we have demonstrated that the base
line mechanical and thermal response to noxious
stimulation is similar in TNFR1/R2 deficient mice
vs wildtype background mice. However, TNFR1/R2
deficient mice develop more severe responses when
[10,16]
similarly treated with various insults
. Animal
models of acute and chronic pancreatitis have been
utilized to examine mechanisms of pathogenesis, and
to test possible therapeutic interventions. One of the
most commonly used pancreatitis models is created by
serial intraperitoneal administration of concentrations
[17]
of caerulein, an ortholog of cholecystokinin . Other
chemically induced models have utilized di-n-butyltin
dichloride (DBTC). DBTC is a polyvinyl carbonate (PVC)
plastic stabilizer/catalyzer additive, insecticide and
biocide in agriculture, and antifouling agent in the
paint and fabric industry that often contaminates food
[18]
and water . Tail vein slow injection of DBTC induces
[6]
relatively unpredictable pancreatitis flares in rats .
However, DBTC injection is tedious and minor leakage
results in tail necrosis, gangrene and animal loss. We
hypothesized that oral administration of DBTC would
provoke persistent and chronic pancreatitis in animals
deficient in TNF-receptors. Similarly, TNFR1/R2 may
accelerate inflammatory response in multiorgans and
contribute to stones formation and fibrosis in hepato
biliary and pancreatic tissues. Here we report a chronic
persistent DBTC-induced inflammatory model by oral
gavage in TNFR1/R2 deficient mice persisting at least
one month allowing more clinically relevant studies in
this model. Pain related behaviors accompanying this
model are characterized.

and provided by Dr. Westlund. Mice were housed in
individual cages with a 10 h/14 h dark/light reversed
cycle to accommodate behavioral test during their
active dark period. Mice were allowed free access
to food and water ad libitum, except 2 h before and
during behavioral testing.

Induction of persistent chronic pancreatitis

Chronic persistent pancreatitis was induced in mice
utilizing DBTC (Dibutyltin dichloride, Sigma-Aldrich,
St Louis, MO). DBTC (10 mg/kg) was dissolved in
95% ethanol (two parts) and then mixed with glycerol
(three parts) and given orally. Mice received DBTC
by oral gavage (200 μl volume). Intragastric gavage
administration was performed by Dr. Oz, an expert
veterinarian scientist, in conscious animals, using
appropriate bended gavage needles (22 gauge, 1 inch
length, 1.25 mm ball diameter). Sham control mice
were given the vehicle (95% ethanol + glycerol, 2:3)
alone and Naïve control animals remained untreated.
Animals were monitored until fully active. In order
nd
to induce chronic inflammation, mice received a 2
treatment by oral gavage within 10 d. Following induc
tion of pancreatitis the animals were monitored daily
for activity, appearance, and signs of abdominal dis
comfort. They were weighed regularly and tested for
hypersensitivity on the hindpaw plantar foot pad and
the shaved abdominal surface. After completion of the
final behavioral testing, one month after induction,
the animals were euthanatized with isoflurane over
exposure, the thorax opened, blood samples collected
by cardiac puncture, and tissue samples collected for
histological evaluation.

Assessment of secondary mechanical allodynia by
testing hindpaw withdrawal threshold

Pain-related behavior was assessed throughout the
study by the determining secondary mechanical
threshold to assess hyperalgesia/allodynia. The von
Frey test is a standard comparison used in the field of
pain research. Day 0, baseline testing to determine
footpad nociceptive responses was performed testing
hindpaw withdrawal latency to mechanical stimuli
with von Frey fibers. Reflex testing for secondary
mechanical hyperalgesia/allodynia with von Frey
fibers was developed by Max von Frey, who in 1896
identified “pain spots” on human skin. Mechanical
nociceptive thresholds were analyzed as described
[10,19]
previously
. Paw withdrawal response latencies
were assessed weekly throughout the study. Mice
were placed into clear cylindrical plastic enclosures (7
cm × 4 cm × 4 cm) on a smooth metal meshed (3
mm × 3 mm) platform (36 cm × 29 cm × 21.5 cm).
Mechanical withdrawal threshold testing was done on
the plantar surface of both hindpaws using a set of
8 von Frey monofilaments [(4.74) 6.0 g; (4.31) 2.0
g; (4.08) 1.0 g; (3.61) 0.4 g; (3.22) 0.16 g; (2.83)
0.07 g; (2.36) 0.02 g; (1.65) 0.008 g]. The von Frey

MATERIALS AND METHODS
Animals

All animal procedures were approved by the University
of Kentucky Institution Animal Care and Use Committee
(IACUC). Mice were monitored daily for continued
weight gain/loss and general health. Health status
and procedures were documented daily on the UK
IACUC Standard Operating Procedure (SOP-102)
Post-Operative Evaluation form. Experiments were
performed using dually deficient TNFR1/R2 mice
(Jackson Laboratory) on a B6129SF2/J background
inbred at the University of Kentucky animal facilities
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filaments were applied perpendicularly to the plantar
surface with sufficient force to bend the monofilament
slightly and held for about 5 s, and 5 to 10 times
with 15 s intervals. A positive response was defined
as an abrupt withdrawal (flick response) of the foot
during stimulation or immediately after the removal of
stimulus. Whenever there was a negative or positive
response, the next stronger or weaker filament was
applied, respectively. Testing proceeded in this manner
until four fibers had been applied after the first one
caused a withdrawal response, allowing the estimation
of the mechanical withdrawal threshold.

against the floor, and abdomen retractions or arching
the back. Recordings were masked and analyzed by the
investigator.

Necropsy and sample collection

Tissue collection: At the end of the one month ex
periment, animals were deeply anesthetized with
isoflurane inhalation. Pancreatic, hepatic, gall bladder
tissues were excised and a portion was fixed in cold 4%
paraformaldehyde in 0.1 mol/L phosphate buffer saline
(PBS). Thymus and splenic tissues were removed,
weighed, and fixed in paraformaldehyde. Colonic
tissues were removed and flushed with cold PBS, and
portion of ascending and descending colon were fixed
for histopathological examinations.

Pain-related behavioral evaluations for abdomen:
Prior to induction of inflammation with DBTC admi
nistration, baseline testing of abdominal nociceptive
responses to mechanical stimuli was performed with
von Frey fibers applied to the upper left abdominal
[10,19]
quadrant skin of mice as previously described
.
Mechanical hypersensitivity in the abdominal area was
quantified by measuring the number of withdrawal
events (either abdominal withdraw from the von Frey
filament or consequent licking of the abdominal area,
or whole body withdrawal) in response to normally
innocuous or sub-threshold mechanical stimuli. Testing
continued weekly throughout the study.

Histopathology

Hepatic and pancreatic samples were collected and
immerse fixed overnight in 4% paraformaldehyde
in 0.1 mol/L PBS, then transferred into 70% ethanol
and embedded in paraffin. Sections were cut (5 μm),
rehydrated, stained with hematoxylin and eosin for
histopathological changes. In order to detect collagen
fiber deposits, sections were further stained with Sirius
Red (Electron Microscopy Sciences, #26357-02), using
[20]
routine histological protocols .

Pancreatitis scores

Evaluation of the pain-related posture: The ab
normal posture of each animal with an affected hindlimb
was given a single score using a subjective pain-related
behavioral scale (spontaneous pain rating score 0-5)
i.e. 0- normal; 1- curling of the toes, 2- aversion of the
paw; 3- partial weight bearing; 4- non-weight bearing
and guarding; and 5- avoidance of any contact with the
hindlimb.

Pancreatic tissues and a portion of the small intestine
along with spleen were removed and processed for
histopathological evaluations of the pancreatitis. The
severity of lesions was scored on a 0-4 grade on the
basis of the histopathological changes as follows: 0 normal pancreatic microstructure, no inflammatory
mononuclear cell infiltration; 1 - slight inflammatory
mononuclear cell infiltration, with no detectable
parenchymal destruction; 2 - mild pancreatitis, edema,
focal parenchymal destruction with mononuclear cell
infiltration; 3 - moderate pancreatitis, with diffuse
parenchyma destruction, presence of necrosis, and
reduced number of islets; and 4 - severe pancreatitis,
parenchyma mostly destroyed and replaced with
adipose tissues, loss of pancreatic islets, presence of
fibrosis and or calculi.

Pain-related gait disturbance: Gait disturbances
(curling toes, limping, guarding, rearing and grooming
were tallied by an observer blinded to treatment group
[10]
as in our previous studies .
Spontaneous visceral pain assessment: The
animals were placed individually in the observation
chamber for a 25 min recording session. The obser
vation chamber is a 28 cm × 17.5 cm × 12.5 cm seethrough plastic home cage with one mirrored side
located in an isolated room with constant “white noise”.
A digital camera located 0.5 meter from the chamber
with an unobstructed view was used to record animals
spontaneous visceral pain related behaviors. The
camera was linked to a computer recording program
for offline data analysis (Logitech Image Studio). The
chamber was washed with a detergent disinfectant
and dried after each use between animals. Postures
defined as statistically significant increase in visceral
pain-related behavior in this study included rearing,
grooming and licking of the lower abdomen, stretching
the abdomen or hindlimb, lowering the abdomen

WJG|www.wjgnet.com

Hepatitis score

A portion of the right lobe from liver tissues of each
mouse was placed in an embedding cassette and
fixed in paraformaldehyde as mentioned above.
The specimens were dehydrated and embedded in
paraffin, and tissue sections of 5 μm were stained
with Hematoxylin Eosin. Each slide was evaluated
under Ziess light microscopy. Hepatic lesions were
graded on a scale of 0 to 4+ based on degeneration,
inflammation, and necrosis as follow: Grade 0 no detectable lesions, degeneration, infiltration of
inflammatory cells, normal tissue appearance; Grade 1
- focal infiltration of inflammatory cells in the tissue and
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A
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P < 0.0001
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0
Sham

Counts/60 s

Weight gain/loss (%)

30

DBTC

-10

20

P < 0.0001

15
10
5
0

-20

Sham
DBTC
Rearing

Figure 1 Percent weight gain in sham-treated controls (Sham) vs weight
loss in dibutyltin dichloride-treated animals. n = 8 animals/group (P < 0.001).
DBTC: Dibutyltin dichloride.

B

Sham
DBTC
Grooming

P < 0.0001
5

hepatocytes degeneration; Grade 2 - mild multifocal
infiltration of inflammatory cells, and hepatocytes
degeneration; Grade 3 - moderate multifocal infiltration
of inflammatory cells and hepatocytes degeneration;
and Grade 4 - severe diffuse infiltration of inflammatory
cells, necrosis, or fibrosis.

Mechanical threshold

4

Colitis evaluation scores

Colonic tissues were flushed with PBS (pH 7.2) and a
portion from proximal and distal colonic tissues were
fixed for histological examinations. The fixed sections
were processed and stained with Hematoxylin Eosin
and slides evaluated by Ziess light microscopy. The
severity of colitis was assessed with a histological
semi-quantitative grading score. The scores were
based on histopathological features with a numeric
value (0: normal to 4: severe) assigned according to
the tissue involvement corresponding to the following
[21,22]
criteria
. Grade 0: No detectable lesions, no
inflammatory cells, and normal mucosal appearance;
Grade 1: Focal inflammatory infiltrate in the mucosa;
Grade 2: Mild multifocal inflammation with moderate
expansion into the mucosa; Grade 3: Moderate multi
focal inflammation with moderate expansion of the
mucosa; and Grade 4: Severe diffuse inflammation
with crypt epithelium disruption and ulceration.

2
1
0
Sham

DBTC

Figure 2 Rearing and grooming rate changes and hindpaw mechanical
threshold modification due to dibutyltin dichloride-treatments. A: Rearing
and grooming rates significantly diminished in dibutyltin dichloride (DBTC)treated animals vs the sham-administered animals and persisted throughout the
study (P < 0.0001); B: Hindpaw withdrawal threshold response to mechanical
stimuli in DBTC-treated animals (DBTC) had significant decreased vs shamadministered control (sham) mice (P < 0.0001). n = 5 animals/group.

naïve control animals. Additionally, sham-treated and
naïve control animals and wildtypes did not develop
any histopathological lesions. Therefore, only shamtreated controls are reported here. Oral administration
of DBTC resulted in weight lost as early as 3 d after
treatment which persisted throughout the study, and
animals developed persistent inflammatory abdominal
and hindpaw hypersensitivity as compared to shamtreated animals. DBTC application induced significant
body weight loss (p < 0.001) in compression to
weight gain in sham-treated control animals. The
st
major weight loss occurred during the 1 wk of DBTC
inoculation when animals lost about 10% of their body
weight, compared to weight gain in sham-treated
animals. The body weight afterward became stable
in DBTC-treated mice until the end of the one month
study, but remained less than the sham-treated group
(Figure 1).

Statistical analysis

All results are expressed as mean and standard error
of mean (± SEM) unless otherwise stated. Data were
analyzed using paired t-test comparison of groups for
histology or analysis of variance (ANOVA) followed by
Bonferroni post hoc comparison using GraphPad Prism
Software for behavioral testing over time (San Diego,
CA, United States). Statistical significance was set at p
≤ 0.05.

RESULTS

Behavioral pain related modifications

Body weight loss

DBTC-treated animals had significant reduction in
physical activities such as, cage crossing, rearing
and grooming activity (p < 0.0001) compared to

No major differences in body weight, behavioral
analysis was detected between sham-treated and

WJG|www.wjgnet.com
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P < 0.0001
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Splenic weight
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Thymic weight
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0
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2.3 g

Sham DBTC
2.8 g

Sham DBTC
3.2 g

Figure 3 Abdominal threshold sensitivity to mechanical stimuli was
determined with different gram forces of von Frey microfilaments as
demonstrated here to 2.3 g (P < 0.001), 2.8 g (P < 0.0001), 3.2 g (P < 0.001),
in dibutyltin dichloride-treated vs sham-treated controls (sham). Data is
presented as the 50% mechanical threshold response. n = 5 animals/group.

Figure 4 Splenic weight as well as splenic length (not shown) signi
ficantly increased in dibutyltin dichloride-treated animals (P < 0.01). In
contrast thymic weight decreased in dibutyltin dichloride-treated (DBTC) vs
the sham-treated (sham) animals (P < 0.001) due to atrophy and depletion of
lymphocytes and thymocytes. n = 8 animals/group.

naïve sham-treated ones presumably attributed
to the abdominal discomfort (Figure 2a). Hindpaw
mechanical threshold was significantly decreased
in DBTC-treated animals (p < 0.0001) tested using
von Frey microfilaments (Figure 2b). In addition,
responses to 3 different von Frey fibers with increasing
grams force applied to the abdominal skin indicated
DBTC-treated animals had significantly decreased
mechanical threshold compared to sham-treated
control (respectively p < 0.0001 from force 2.3 g, 2.8
g, p < 0.001 to force 3.22 g) (Figure 3). In contrast
sham-treated animals demonstrated a partial visceral
response to the higher filaments with forces of 3.22 g
and above.

thickening which were particularly prominent in the
vicinity of the primary duct, as well in surrounding
lobular pancreatic parenchyma as confirmed with
Sirius Red histopathological studies.
Also noted was loss of microstructure indicated by
the presence of irregular and degenerated islets, along
with vacuolization and necrosis of β cells accompanied
by invasion of inflammatory cells. The sizes as well as
the numbers of the pancreatic islets were significantly
diminished in DBTC-treated compared with the shamtreated animals (Figure 5b). A few small and shrunken
islets were scattered throughout the pancreatic
parenchyma, but overall loss of β cells was evident.
In addition, pancreatic ducts had become thickened
and expanded containing traces of debris and calculi
formation (Figure 6a). Extent of pancreatic damage
scored (0- normal to 4 most severe) were 3.6 ± 0.4
(severe) in DBTC-treated in contrast to score 0 (normal)
for sham-treated animals.

Splenomegaly and thymic degeneration

DBTC animals developed splenic hypertrophy with
significant increase in weight and length of the
spleens (p < 0.01). Splenic histopathologic studies
demonstrated loss of medulla, irregular formation of
trabecules, with captured trace of blirubin and bile
deposits. In contrast, thymic tissues from DBTCtreated animals showed central degeneration and
atrophy. The thymus was atrophied, and thymic weight
significantly decreased in DBTC-treated animals (p <
0.001) compared to sham-treated animals (Figure 4).

Gall bladder

Gall bladder showed extensive expansion with ductal dis
tension and occasional detected bile stones (Figure 6b).

Hepatitis

Hepatic tissues became enlarged, friable and pale or
yellowish in color with a spotted appearance indicating
moderately severe hepatitis. Macroscopic hepatic
injuries were evidenced with activation of stellate
cells, degeneration of hepatocytes, and multifocal
and central necrosis (Figure 7a). Additionally, hepatic
structure showed fatty degeneration of hepatocytes,
and periportal infiltration of inflammatory cells,
along with presence of visible ductal dilation. Fibrotic
thickening was prominent in the vicinity of portal
ducts, and surrounding lobular hepatic parenchyma
as confirmed with Sirius Red histopathological studies.
The severity of hepatitis was scored 3.7 ± 0.2 (severe)
in DBTC-treated animals compared to the score 0

Pancreatitis

Sham-treated animals demonstrated normal pan
creatic structures with prominent islets (Figure 5a).
In contrast, DBTC-treated animals developed gross
as well as micropathology confirming the moderate to
severe chronic pancreatitis. Pancreatic parenchyma
presented with edema, congestion, distortion of
microarchitecture, and infiltration of inflammatory
cells. Pancreatic and acinar cells showed degeneration,
fatty necrosis, and fibrosis. The pancreatic ducts
became prominent and distended in DBTC-treated
animals. These findings were consistent with fibrotic
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A

B

Figure 5 Pancreatic photomicrographs from sham-treated normal control (A) compared to dibutyltin dichloride-treated animal (B). A: Pancreas:
Photomicrograph demonstrates sham-treated control pancreas with normal pancreatic microstructure and islet cells. Representative slide from n = 8 animals/group;
B: Pancreatitis: Photomicrograph illustrates pancreas from a dibutyltin dichloride-treated animal with significant loss of pancreatic structure and islets, acinar atrophy,
infiltration of inflammatory cells, fatty deposits and edema (magnification × 40). Representative slide from n = 8 animals/group.

A

B

Figure 6 Photomicrograph from pancreatic ductal calculi formation (A), as well as hepatic and gall bladder gross pathological structure (B) in dibutyltin
dichloride-treated animals. A: Calculi formation: Photomicrograph illustrates histopathologic structure from a representative pancreas of a dibutyltin dichloride-treated
animal to demonstrate ductal distension and calculi formation. Representative slide from n = 8 animals/group (magnification × 40); B: Photograph illustrates hepatic
gross lesions (red arrows), expanded bile duct (blue arrows) and gall bladder (white arrow) from DBTC-treated animal. Representative from n = 8 animals/group.

A

B

Figure 7 Photomicrograph of hepatitis (A) and colitis (B) from dibutyltin dichloride-treated animals. A: Hepatitis: Photomicrograph illustrates necrosis of
hepatocytes, infiltration of inflammatory cells (magnification × 40). Representative slide from n = 8 animals/group; B: Colitis: Photomicrograph demonstrates distortion
of colonic microstructure, loss of brush boarder epithelial cells, infiltration of inflammatory cells into mucosa and cryptic abscess formation. Representative slide from n
= 8 animals/group.

(normal) in sham-treated animals.

thickening of mucosa due to invasion of inflammatory
cells, and some cryptic microabscess formation,
presenting advanced colitis (Figure 7b). Colonic lesions
and colitis in DBTC-treated animals were scored 3.4 ±
0.3 (moderately severe) compared to 0 (normal) for

Colitis

Colonic tissue showed extensive necrosis and loss of
intestinal epithelial cells, distortion of cryptic structures,
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the sham-treated animals.

Additionally, the mesenchyme-specific transcription
factor forkhead box f1 (Foxf1) in liver is specifically
expressed in hepatic stellate cells. Recently, a lipid
based liver-specific delivery system also called “dbtc”
is reported to be efficient to transfer the Foxf1 siRNA
to activated hepatic stellate cells and silence genes
expressed in different cell types in liver when used in
an acute mouse model of bile duct ligation-induced
[27]
secondary cholestasis .
Pancreatitis models are divided into surgically
induced and chemical administration induced hyper
secretion of the pancreatic enzymes. The surgical
models include ligation and/or cannulation of the
biliopancreatic ducts with infusion of variety of so
lutions, or the formation of closed duodenal loops.
Pancreatic fibrosis in bile duct ligated rats is a difficult
model to induce and requires increased stimulation.
Chemical secretagogues (caerulein or l-arginine)
include administration of DBTC to cause a partial
blockage of the pancreatic ducts to induce pancreatic
[28]
disease through enzymic reflux into the gland .
Various environmental chemicals have been
implicated in the induction of autoimmune responses.
Di-n-dibutyltin dichloride is an organotin compound
and PVC plastic additive that frequently released to
contaminate food and water. As eventually DBTC is
degraded in the environment with possible harmful
[29]
effects on man and animals . Some therapeutic
indications of DBTC include at a dose of 10 mg/kg
per day for 5 consecutive days effective to eliminate
[23]
Trypanosoma brucei infection in mice . LD50 of DBTC
[30]
is reported to be 90 mg/kg . Metabolism of DBTC
by cytochrome P450 enzymes plays an important
role in the induction of biological effects, as DBTC
with affinity for mitochondria depresses respiration
and elevates serum enzymatic activities resulting in
[31]
hepatic injuries . Thymus atrophy noted in the current
investigation was similar to that reported as a con
sequence rather than a cause in DBTC-intraperitoneal
[32]
injected rats . Increased proliferin expression and
promotion of morphological thymic transformation
reportedly occurring at similar concentrations most
probably are DBTC-induced thymus involution. Indeed,
this reaction is due to antiproliferative activity of DBTC,
as observed by inhibition of thymidine incorporation of
[32]
thymocytes isolated from DBTC-treated rats . After
administration of 4-61 mg/kg iv or 120-240 mg/kg
oral DBTC, a dose dependent reversible reduction
of thymus weight and number of thymocytes were
observed in mice. Iv administration of DBTC highly
increased the level of total bilirubin in serum of
these animals. But, the level of bilirubin in serum did
not correlate with the thymotoxic effects of DBTC
[33]
in mice . Of interest, toxicity of DBTC in mice is
reported after 3 consecutive daily high doses of 50
mg/kg, killing 75% and the survivors developed
severe hepatic and bile duct damage. While 3 daily
doses of 20 mg/kg caused only mild bile duct and
[34]
liver lesions .

DISCUSSION
Here our findings may provide a new model to
better approach investigation of chronic multiorgan
inflammatory and visceral pain in murine model and
to study possible potential targets in this model for the
treatment of chronic hepatobiliary and pancreatitis.
Acute pancreatitis is manifested by histopatholo
gical transformations, including the presence of in
flammatory mediators, acinar atrophy, fat necrosis,
[23]
intraductal hemorrhage, and stromal proliferation .
Chronic pancreatitis is distinguished by recurrent or
continuous inflammation of pancreatic progressive
atrophy and irreversible fibrosis, with demise of
exocrine and endocrine malfunction in severe forms.
While, severe and uninhibited abdominal pain is the
main aspect of persistent pancreatitis, the mechanism/
s by which the pain is induced is poorly explored
possibly due to a lack of available appropriate animal
[24]
model to mimic chronic pancreatitis . In current
study the TNFR1/R2 deficient animals displayed
significant pain related modifications such as decreases
in mechanical threshold after DBTC treatment that
persisted through the one month experiment until
the end of the study. The significant decreases in
mechanical threshold were detected on foot pads and
abdomen after the induction of the injury as compared
with sham treated animals.
Although, chronic pancreatitis in human is dis
tinguished by irreversible fibrosis, yet pancreatic
[25]
fibrosis in animal models are mainly reversible .
Indeed persistent fibrosis in vital organs results in
significant morbidity and mortality worldwide. While,
organ fibrogenesis is typically the end product of
various non-resolving or repetitive injuries such as
chronic infection and radiation exposure; abnormal
repair reaction followed by tissue injuries to contri
bute to the progression of organ fibrosis. Indeed,
fibrogenesis is required in natural wound healing
process, persistent fibrogenesis in organs can lead
[1,2]
to devastating symptoms and organ failure . At
the cellular level fibrogenesis is remarkably similar
progress in different organs and can cause generalized
fibrosis in these tissues. Yet, currently there is no
appropriate model available to study systemic fibrosis.
Similarly chronic hepatitis and hepatic fibrosis result
from excess extracellular matrix produced primarily by
hepatic stellate cells. We and other investigators have
shown that proinflammatory cytokines (e.g., TNFα)
and other inflammatory mediators such as growth
factors are regulated by matrix metalloproteinase
[20,26]
(MMPs) expressions
. Further activation of Stellate
cells is major event in hepatic fibrosis formation
caused by multiple injuries due to chemicals, infectious
agents, surgical and/or inflammatory cytokine and
chemokines which prompt proliferation and transfor
mation of stellate cells to secret extra cellular matrix.
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In another study, mice were given DBTC at 8, 15,
or 30 mg/kg per day by gavage on days 0-3 or days 4-7
and sacrificed on day 18 of pregnancy. The incidence
of embryonic loss increased on days 0-3 at 15 mg or
over and, on days 4-7 with 8 mg/kg bw/d and higher.
However, no increase in the rate of fetus malformations
was observed after the DBTC administration. A decline
in the serum progesterone levels was noted in dams
given DBTC at 30 mg/kg per day, which might have
affected the pregnancy initiation, maintenance, and
[35]
loss when administered during early pregnancy .
Non-alcoholic steatohepatitis (NASH), the most
common hepatic disorder, is manifested with inflam
mation, hepatocyte injury, cell death, fibrosis and
[26]
multiorganelle failure, leading to cirrhosis . Previously
we reported cytokine/chemokine, extracellular matrix
accumulation and metalloproteinase upregulation
[20]
in a dietary deficient NASH model . RT-PCR mea
surements showed a significant overexpression of
inflammatory cytokines [TNFα, transforming growth
factor (TGF-β), interleukin (IL-1β), IL-6], suppressor
of cytokines signaling1 and genes involved in tissue
remodeling and fibrosis (MMPs, collagen-α1) in the
hepatic tissues of rats fed methionine-choline deficient
[20]
diet .
Furthermore, using DBTC tail injection rat model we
have shown implication of the endothelin cascade gene
expression as a major contributing factor in pancreatic
pain in both pancreatitis and potential pancreatic
[6]
cancer . In the present study oral inoculation of
DBTC in TNFR1/R2 deficient mice induced a chronic
persistent multiorgan hepatobiliary pancreatitis as
confirmed by pathological studies including biliary
dilation, loss of hepatic and pancreatic architecture
and islets, edema in parenchyma, infiltration of
inflammatory cells, degeneration, vacuolization and
fibrosis, and pancreatic necrosis of acinar cells. Pain
related behaviors were increased in animals with
pancreatic inflammation including visceral painrelated behavior and secondary cutaneous mechanical
hypersensitivity which increased greater than 2-fold.
Here lack of TNF receptors appears to accelerate
the inflammatory response in multiple organs and
contribute to fibrosis in hepatobiliary and pancreatic
tissues. A serum proteome profiling analysis in our
previous study in TNFR1/R2 deficient mice with
pain related behaviors in an arthritis model revealed
high levels of serum inflammatory factors. The
inflammatory factors included TNFα, which is regulated
by the activation of normally T-cell expressed and
secreted (RANTES), chemokine (C-X-C motif) ligand
9 [CXCL9 (MIG)], chemokine (C-X-C motif) ligand 10
[CXCL10 (IP-10)], and chemokine (C-C motif) ligand 2
[10]
[CCL2 (MCP-1)] .
Primary sclerosing cholangitis is a complex hepatic
disorder, characterized by chronic inflammation of the
biliary epithelium, and cholestasis resulting in multifocal
bile duct strictures, fibrosis of hepatic parenchyma
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and biliary tract leading to cirrhosis and malignancy.
The etiology of primary sclerosing cholangitis is not
[5]
fully discovered and no effective therapy is available .
Gallstone, one of the most prevalent gastrointestinal
complications, is multifactoral, with serious outcomes
such as acute gallstone pancreatitis and gallbladder
cancer. Gallstone disease is a chronic recurrent
hepatobiliary complication which is manifested by
creation of gallstones in the hepatic and bile duct,
or gallbladder. It is manifested by dysfunctional
[7]
metabolism of cholesterol, bilirubin and bile acids .
Other factors may involve genetic, environmental
and steroids. The prevalence of gallstone disease has
increased because of sedentary lifestyle and poor
diets. Gallstones are known as a common cause of
pancreatitis. From 932 patients with acute pancreatitis
[36]
40% had gallstones, and 22% alcohol induced .
Further, pancreatitis is frequent amongst IBD patients.
Gallstones are reported as the most frequent cause
of pancreatitis in IBD patients which cause growing
[37]
diagnostic challenges . Thus, this model may fa
cilitate study of fibrogenesis and/or fibrosis resolution
in multiple vital organs leading to development of
novel technologies and therapeutic strategies aimed at
lessening organ fibrosis.
In conclusions, this is the first report of a chronic
inflammatory multiorgan hepatobiliary pancreatitis
along with fibrosis and calculi formation model
that can be induced reliably with use of oral DBTC
administration in TNFR1/R2 deficient mice. Future
studies will utilize this model in investigations of antifibrotic and analgesic therapeutics.
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COMMENTS
COMMENTS
Background

Chronic multiorgan, pancreatitis and hepatobiliary complications manifested
with irreversible fibrosis and spontaneous visceral pain in patients. Currently
there is no cure or reliable model available for chronic pancreatitis or multiorgan
fibrosis other than repeated dosing with chemical caerulein to produce acute
flares. An appropriate murine model to mimic the syndrome is desirable.
Pancreatic fibrosis in bile duct ligated rats is a difficult model to induce and
requires other increased stimulations. The prevalence of gallstone disease has
increased because of sedentary lifestyle and poor diets. Dibutyltin dichloride
(DBTC) is a biocide, and antifouling agent in the paint and fabric industry. Tail
vein injection of DBTC induces unpredictable pancreatitis flares in rats, DBTC
injection is tedious, and minor leakage results in tail gangrene and animal loss.
TNFα proinflammatory cytokine initiates inflammation through its 2 receptors,
TNFR1/R2. We devised a new chronic model of pancreatitis and multiorgan
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inflammation in TNFR1/R2 deficient mice using oral DBTC.
4

Research frontiers

Currently, there is no cure or reliable model available for chronic pancreatitis
and multiorgan fibrosis in mice. Persistent pancreatitis manifests with severe
abdominal pain, but the mechanism/s by which induced is/are poorly explored
possibly due to lack of appropriate models. Three daily doses of 20 mg/kg
DBTC caused only mild bile duct and liver lesions, while 3 consecutive
daily doses of 50 mg/kg DBTC were toxic and killed 75% of mice. TNFα
proinflammatory cytokine initiates inflammation through its 2 receptors, TNFR1/
R2. Proteome profiling analysis in our previous study in TNFR1/R2 deficient
mice with persistent pain related behaviors in an arthritis model revealed high
levels of serum inflammatory cytokines likely responsible for the multiorgan
inflammatory response in this model.

5

6

7

Innovations and breakthroughs

8

This is the first report of a chronic inflammatory hepatobiliary pancreatitis,
colitis and stone formation model that can be induced reliably with use of oral
DBTC-administration in TNFR1/R2 deficient mice. These findings provide
this new murine model to better approach investigation of chronic multiorgan
inflammatory and visceral pain in murine mode. In addition, to facilitate study
of fibrogenesis and/or fibrosis resolution in multiple vital organs leading
to development of novel technologies and therapeutic strategies aimed at
lessening organ fibrosis.

9
10

Applications

This chronic inflammatory hepatobiliary pancreatitis, colitis/fibrosis and stone
formation model can be induced reliably utilizing oral DBTC in TNFR1/R2
deficient mice. The model can be used to investigate chronic multiorgan
inflammatory and visceral pain in mice to explore the mechanisms of injury
and to study of fibrogenesis and/or fibrosis resolution in multiple vital organs
leading to development of novel technologies and therapeutic strategies aimed
at lessening organ fibrosis. This study grants ability for further investigation
into the use of this model to explore mechanisms of multiorgan injury, the
biochemical players and the therapeutic exploration for devastating chronic
multiorgn inflammatory and fibrogenesis such as cystic fibrosis and systemic
sclerosis as well as cholangitis.

11

12
13
14

Terminology

TNFR1/R2 deficient mice are transgenic animals lacking tumor necrosis factor
receptor 1 and 2 with constant higher proinflammatory TNFα levels compared
to wildtype background animals. Multiorgan damage, when 2 or more organs
involved in the course of injury. Fibrogenesis is a process usually followed
chronic inflammatory to form fibrous structures in and around tissues. Pain
related mechanical hypersensitivity, is measured by von Frey microfilament
(an accepted standard procedure), demonstrating decreased tolerance to
a simple touch manifested with withdraw to protect against induced excess
pressure while normal animals tolerate the mechanical touch with no withdrawal
response to the fine microfilament touch.

15

16

17

Peer-review

This is an interesting and well-written paper. The author provided that TNFR1/
R2 deficient mice treated with DBTC reveal the severe chronic injury of various
internal organs which was proved with usage of histological methods.
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